(Q43239893)

English

Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy

scientific article published in June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 November 2017

Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathy (English)

1 reference

Europe PubMed Central

17 November 2017

1 reference

based on heuristic

inferred from title

author name string

Kum Hyun Han

1

1 reference

Europe PubMed Central

17 November 2017

Sang Youb Han

2

1 reference

Europe PubMed Central

17 November 2017

Han Seong Kim

3

1 reference

Europe PubMed Central

17 November 2017

Young Sun Kang

4

1 reference

Europe PubMed Central

17 November 2017

Dae Ryong Cha

5

1 reference

Europe PubMed Central

17 November 2017

publication date

1 June 2010

1 reference

Europe PubMed Central

17 November 2017

1 reference

Europe PubMed Central

17 November 2017

33

1 reference

Europe PubMed Central

17 November 2017

3

1 reference

Europe PubMed Central

17 November 2017

137-143

1 reference

Europe PubMed Central

17 November 2017

https://scigraph.springernature.com/pub.10.1007/s10753-009-9167-6

0 references

Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS10753-009-9167-6

21 January 2018

Effect of retinoic acid in experimental diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentoxifylline attenuated the renal disease progression in rats with remnant kidney.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentoxifylline inhibits platelet-derived growth factor-stimulated cyclin D1 expression in mesangial cells by blocking Akt membrane translocation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasodilator agents modulate rat glomerular mesangial cell growth and collagen synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective Antihypertensive Treatment Postpones Renal Insufficiency in Diabetic Nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19921414

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10753-009-9167-6

1 reference

Europe PubMed Central

17 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43239893&oldid=1984694149"